UK's health regulator on Monday approved GSK's twice-yearly drug for use as an add-on treatment for asthma in patients aged ...

Emma Walmsley’s praise for US pharmaceutical market piles pressure on UK government ...

RESEARCH TRIANGLE PARK – Drug giant GSK is moving its corporate headquarters to downtown London, the company announced today. “Our new headquarters represents an important next step for GSK,” said CEO ...

A trio of drugmakers are treading the boards to raise awareness of global antimicrobial resistance (AMR). | A trio of ...

On Monday, Pfizer Inc. (NYSE:PFE) stock is trading higher with a session volume of 31.16 million as per data from Benzinga Pro. Activist investor Starboard Value has invested approximately $1 billion ...

Boss of drugs giant GSK declares US best place to invest - Dame Emma Walmsley said the US was still leading the way for new ...

(Alliance News) - GSK PLC on Monday said Exdensur has been approved in the UK, for the treatment of asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps.

GSK’s London-listed shares fell even more swiftly than their ADRs to news that advisers to the Centers for Disease Control and Prevention shifted their recommendations for who should be vaccinated ...

Olympic officials in London are mounting a full court press against performance-enhancing drugs. A key part of that push is state-of-the-art testing facilities. That’s where GlaxoSmithKline (GSK) — ...

Settlement reached over mRNA-based COVID vaccines CureVac and GSK get $740 million upfront, and royalties BioNTech's deal to buy CureVac on track GSK's own lawsuits against Pfizer, BioNTech unaffected ...